We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+13.33%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$273B
AUM Growth
+$112B
Cap. Flow
+$85.1B
Cap. Flow %
31.22%
Top 10 Hldgs %
26.87%
Holding
5,469
New
898
Increased
2,915
Reduced
940
Closed
253

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 8.18%
3 Consumer Discretionary 7.81%
4 Healthcare 7.12%
5 Communication Services 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KB icon
4476
KB Financial Group
KB
$42.6B
$113K ﹤0.01%
2,722
ONEQ icon
4477
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
$113K ﹤0.01%
1,900
GBIO
4478
DELISTED
Generation Bio
GBIO
$112K ﹤0.01%
6,786
+5,427
+399% +$94.6K
ATYR
4479
aTyr Pharma
ATYR
$49.2M
$111K ﹤0.01%
+78,972
New +$101K
AUGX
4480
DELISTED
Augmedix, Inc. Common Stock
AUGX
$110K ﹤0.01%
18,855
-3,461
-16% -$18.2K
ZURA icon
4481
Zura Bio
ZURA
$542M
$110K ﹤0.01%
23,611
+21,406
+971% +$107K
PROK icon
4482
ProKidney
PROK
$337M
$110K ﹤0.01%
61,815
+48,234
+355% +$103K
CPSS icon
4483
Consumer Portfolio Services
CPSS
$208M
$110K ﹤0.01%
11,714
+10,273
+713% +$95.9K
CAE icon
4484
CAE Inc. Common Shares
CAE
$8.61B
$108K ﹤0.01%
5,015
-90,065
-95% -$1.92M
CARM
4485
DELISTED
Carisma Therapeutics
CARM
$107K ﹤0.01%
36,598
+31,726
+651% +$94.3K
TR icon
4486
Tootsie Roll Industries
TR
$2.99B
$107K ﹤0.01%
3,519
-2,013
-36% -$59K
IPSC icon
4487
Century Therapeutics
IPSC
$343M
$107K ﹤0.01%
32,184
+28,035
+676% +$51.1K
IIF
4488
Morgan Stanley India Investment Fund
IIF
$220M
$107K ﹤0.01%
4,000
ACB
4489
Aurora Cannabis
ACB
$185M
$106K ﹤0.01%
22,257
-2,450
-10% -$11.8K
GRCL
4490
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$106K ﹤0.01%
10,517
-301,003
-97% -$1.37M
WKHS icon
4491
Workhorse Group
WKHS
$35.2M
$103K ﹤0.01%
95
+85
+850% +$102K
ONC
4492
BeOne Medicines Ltd
ONC
$36.7B
$102K ﹤0.01%
568
-250
-31% -$45.2K
HAS icon
4493
PUT
Hasbro
HAS
$12.9B
$102K ﹤0.01%
2,000
-168,400
-99% -$8.51M
DKL icon
4494
Delek Logistics
DKL
$3.13B
$102K ﹤0.01%
2,354
WMPN
4495
DELISTED
William Penn Bancorporation Common Stock
WMPN
$102K ﹤0.01%
8,314
-3,793
-31% -$46.5K
SLRC icon
4496
SLR Investment Corp
SLRC
$705M
$101K ﹤0.01%
+6,741
New +$101K
FSV icon
4497
FirstService
FSV
$6.27B
$99.8K ﹤0.01%
616
+601
+4,007% +$90.9K
SHIP icon
4498
Seanergy Maritime Holdings
SHIP
$374M
$99.7K ﹤0.01%
12,732
NOA
4499
North American Construction
NOA
$393M
$99.1K ﹤0.01%
4,753
-207
-4% -$4.27K
CUTR
4500
DELISTED
Cutera, Inc.
CUTR
$97.3K ﹤0.01%
27,609
+4,258
+18% +$13K

Similar funds

Barclays's Q4 2023 Portfolio in Review

As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $673M trimmed.

  • Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
  • Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
  • Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
  • Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
  • Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
  • Barclays opened 898 new positions and closed 253 in Q4 2023.
  • Barclays's portfolio value rose 70% quarter-over-quarter to $273B.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.